Exp Clin Endocrinol Diabetes 2011; 119(1): 56-58
DOI: 10.1055/s-0030-1265162
Short Communication

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Glycaemic Rises after Waking Up in Response to an Alarm Clock in Type 1-diabetic Patients Analysed with Continuous Glucose Monitoring (GlucoDay® S)

C. Berndt-Zipfel1 , L. Köthe1 , B. Nawrodt1 , B. Mraz2 , A. Patzelt-Bath3 , M. A. Nauck1
  • 1Diabeteszentrum Bad Lauterberg im Harz, Germany
  • 2A. Menarini Diagnostics, Berlin, Germany
  • 3Berlin-Chemie AG, Berlin, Germany
Further Information

Publication History

received 14.04.2010 first decision 08.08.2010

accepted 24.08.2010

Publication Date:
18 January 2011 (online)

Abstract

Aims: Waking up in response to an alarm-clock may evoke a stress reaction that leads to rising glucose concentrations.

Method: 30 type 1-diabetic patients participated in 3 overnight conditions: (a) with an alarm-clock set at 2 h intervals for glucose self monitoring, (b) with a nurse performing blood glucose determinations, and (c) with the patients left undisturbed. Continuous glucose monitoring (CGM) was performed with a GlucoDay® S device.

Results: After waking up in response to an alarm-clock, CGM-determined glucose concentrations rose by 18±6 mg/dl at 4 a.m. (p=0.0003), whereas negligible increments were seen with nurse assistance (e. g., 0±4 mg/dl at 4 a.m.).

Conclusions: Waking up in response to an alarm-clock leads to an arousal reaction that causes significant elevations in glucose concentrations. Continuous glucose monitoring is a suitable method to detect such short-lived increments in glucose concentrations. But at the moment the CGMS is not able to substitute for inpatient glucose profiles. Registered with ClinicalTrials.gov, Identification number NCT00740012.

References

  • 1 Berndt C, Köthe L, Nawrodt B. et al . Glycaemic rises after waking up in response to an alarm clock during the night in type 1-diabetic patients can be avoided by experienced nurses drawing blood in a hospital setting as shown by continuous glucose monitoring (GlucoDay) (abstract 14).  Diabetologia. 2008;  51 (Suppl. 1) S12
  • 2 DeVries JH, Wentholt IM, Masurel N. et al . Nocturnal hypoglycaemia in type 1 diabetes – consequences and assessment.  Diabetes Metab Res Rev. 2004;  20 (Suppl. 2) S43-S46
  • 3 Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B. Reproducibility and reliability of hypoglycaemic episodes recorded with Continuous Glucose Monitoring System (CGMS) in daily life.  Diabet Med. 2005;  22 858-862
  • 4 Jones TW, Porter P, Sherwin RS. et al . Decreased epinephrine responses to hypoglycemia during sleep.  N Engl J Med. 1998;  338 1657-1662
  • 5 Kaufman FR, Austin J, Neinstein A. et al . Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes.  J Pediatr. 2002;  141 625-630
  • 6 Lepore M, Pampanelli S, Fanelli C. et al . Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.  Diabetes. 2000;  49 2142-2148
  • 7 Maran A, Crepaldi C, Tiengo A. et al . Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis.  Diabetes Care. 2002;  25 347-352
  • 8 Trinder J, Allen N, Kleiman J. et al . On the nature of cardivascular activation at an arousal from sleep.  Sleep. 2003;  26 543-551

Correspondence

Prof. Dr. med. M. A. Nauck

Diabeteszentrum Bad

Lauterberg

Kirchberg 21

37431 Bad Lauterberg im Harz

Germany

Phone: +49/5524/81218

Fax: +49/5524/81398

Email: M.Nauck@diabeteszentrum.de